Simplex Trading’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-500
| Closed | -$45K | – | 8439 |
|
|
2025
Q3 | $45K | Sell |
500
-100
| -17% | -$8.15K | ﹤0.01% | 6558 |
|
|
2025
Q2 | $39K | Buy |
600
+100
| +20% | +$6.51K | ﹤0.01% | 6159 |
|
|
2025
Q1 | $33K | Buy |
+500
| New | +$29.9K | ﹤0.01% | 6152 |
|
|
2024
Q4 | – | Sell |
-800
| Closed | -$47K | – | 8428 |
|
|
2024
Q3 | $47K | Sell |
800
-400
| -33% | -$24.4K | ﹤0.01% | 5928 |
|
|
2024
Q2 | $76K | Sell |
1,200
-1,200
| -50% | -$77.9K | ﹤0.01% | 5653 |
|
|
2024
Q1 | $165K | Buy |
2,400
+2,300
| +2,300% | +$139K | ﹤0.01% | 5060 |
|
|
2023
Q4 | $5K | Sell |
100
-5,400
| -98% | -$297K | ﹤0.01% | 7821 |
|
|
2023
Q3 | $319K | Buy |
5,500
+2,600
| +90% | +$150K | ﹤0.01% | 3870 |
|
|
2023
Q2 | $156K | Buy |
2,900
+2,800
| +2,800% | +$124K | ﹤0.01% | 4583 |
|
|
2023
Q1 | $3K | Sell |
100
-500
| -83% | -$21.1K | ﹤0.01% | 8267 |
|
|
2022
Q4 | $24K | Buy |
600
+400
| +200% | +$15K | ﹤0.01% | 6678 |
|
|
2022
Q3 | $6K | Sell |
200
-1,000
| -83% | -$34.2K | ﹤0.01% | 8611 |
|
|
2022
Q2 | $35K | Sell |
1,200
-200
| -14% | -$5.77K | ﹤0.01% | 6936 |
|
|
2022
Q1 | $39K | Sell |
1,400
-5,600
| -80% | -$209K | ﹤0.01% | 7460 |
|
|
2021
Q4 | $322K | Buy |
7,000
+6,500
| +1,300% | +$279K | ﹤0.01% | 4442 |
|
|
2021
Q3 | $17K | Hold |
500
| – | – | ﹤0.01% | 8551 |
|
|
2021
Q2 | $17K | Buy |
500
+494
| +8,233% | +$16.8K | ﹤0.01% | 8701 |
|
|
2021
Q1 | $21K | Sell |
6
-36
| -86% | -$1.13K | ﹤0.01% | 7403 |
|
|
2020
Q4 | $121K | Buy |
+42
| New | +$1.2K | ﹤0.01% | 5241 |
|
|
2020
Q3 | – | Sell |
-7
| Closed | -$22K | – | 7725 |
|
|
2020
Q2 | $22K | Sell |
7
-10
| -59% | -$359 | ﹤0.01% | 6132 |
|
|
2020
Q1 | $69K | Buy |
17
+5
| +42% | +$266 | ﹤0.01% | 4776 |
|
|
2019
Q4 | $74K | Sell |
12
-2
| -14% | -$132 | ﹤0.01% | 4827 |
|
|
2019
Q3 | $102K | Sell |
14
-35
| -71% | -$2.62K | ﹤0.01% | 4302 |
|
|
2019
Q2 | $402K | Buy |
49
+5
| +11% | +$356 | ﹤0.01% | 2783 |
|
|
2019
Q1 | $310K | Sell |
44
-16
| -27% | -$941 | ﹤0.01% | 3161 |
|
|
2018
Q4 | $270K | Buy |
60
+17
| +40% | +$891 | ﹤0.01% | 2826 |
|
|
2018
Q3 | $243K | Buy |
43
+23
| +115% | +$1.41K | ﹤0.01% | 3427 |
|
|
2018
Q2 | $133K | Sell |
20
-116
| -85% | -$7.24K | ﹤0.01% | 3956 |
|
|
2018
Q1 | $2K | Buy |
+136
| New | +$8.63K | ﹤0.01% | 5181 |
|
|
2017
Q4 | – | Sell |
-302
| Closed | -$2K | – | 5927 |
|
|
2017
Q3 | $2K | Buy |
302
+215
| +247% | +$10.3K | ﹤0.01% | 4990 |
|
|
2017
Q2 | $81K | Sell |
87
-424
| -83% | -$20.5K | ﹤0.01% | 1942 |
|
|
2017
Q1 | $77K | Buy |
511
+468
| +1,088% | +$26.3K | ﹤0.01% | 1970 |
|
|
2016
Q4 | $60K | Buy |
43
+3
| +8% | +$183 | ﹤0.01% | 1977 |
|
|
2016
Q3 | $1K | Sell |
40
-14
| -26% | -$876 | ﹤0.01% | 5227 |
|
|
2016
Q2 | $4K | Buy |
54
+8
| +17% | +$389 | ﹤0.01% | 4376 |
|
|
2016
Q1 | $11K | Buy |
46
+12
| +35% | +$407 | ﹤0.01% | 3363 |
|
|
2015
Q4 | $45K | Sell |
34
-3
| -8% | -$129 | ﹤0.01% | 1993 |
|
|
2015
Q3 | $26K | Sell |
37
-6
| -14% | -$341 | ﹤0.01% | 2521 |
|
|
2015
Q2 | $4K | Buy |
43
+10
| +30% | +$595 | ﹤0.01% | 3772 |
|
|
2015
Q1 | $10K | Buy |
+33
| New | +$2.01K | ﹤0.01% | 2929 |
|
Other funds holding ANIP
VCM
SCM
TCM
GAM
DTC
Simplex Trading's ANIP Position: Q1 2026 in Review
Simplex Trading reduced its ANI Pharmaceuticals (ANIP) stake by 17% in Q1 2026, selling an estimated $54.1K and leaving 3,459 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #3952.
Simplex Trading first reported a position in ANIP in Q3 2015 and has held it in 24 quarters since. The position peaked at $882K in Q3 2019. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.
- Simplex Trading held 3,459 shares of ANI Pharmaceuticals worth $266K as of Q1 2026.
- Simplex Trading sold 693 ANI Pharmaceuticals shares in Q1 2026, an estimated $54.1K.
- ANI Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3952 holding.
- Simplex Trading first reported a position in ANI Pharmaceuticals in Q3 2015 and has held it in 24 quarters since.
- Simplex Trading's ANI Pharmaceuticals position peaked at $882K in Q3 2019.
- 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.